Brenda Medina
- Indexed articles, last 90 days
- 2
- Latest publication
- Jul 10, 2026
- Outlet visibility, for International Consortium of Investigative Journalists - ICIJ
- Top 1M sites
- Earliest in this view
- Jul 10, 2026
Latest articles
Merck takes Austria’s Keytruda price transparency battle to top court as journalists fight for information - ICIJ (opens the original)
Read excerpt
A battle over whether the public has the right to know how much Austria’s public hospitals pay for the blockbuster cancer drug Keytruda is heading to the Constitutional Court. Pharmaceutical giant Merck & Co.’s Austrian subsidiary is challenging journalists’ efforts to obtain that information in a case likely to test the limits of the country’s freedom of information law, which was enacted in September 2025. The dispute stems from a freedom-of-information campaign by outlets profil and Der Stand
Merck takes Austria’s Keytruda price transparency battle to top court as journalists fight for information (opens the original)
Read excerpt
The case stems from ICIJ’s Cancer Calculus investigation into the world's best-selling drug’s sky-high price and its global consequences.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1M sites
For International Consortium of Investigative Journalists - ICIJ, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.